Volume 12, number 1
 PDF Downloads: 1001

A new HPLC Method for Determination of Carvedilol in Human Plasma and its Application in Bioequivalence Studies

N. Adib and M. Shekarchi*

Food and Drug Lab Research Center, Ministry of Health, Tehran, Iran.

ABSTRACT: A simple, rapid and sensitive isocratic reversed-phase high performance liquid chromatography method for the determination of carvedilol in human plasma has been developed. After extraction with methanol chromatographic analysis of carvedilol in plasma was achieved on a μ-bondapack C18 column using acetonitrile- potassium dihydrogen phosphate (30: 70v/v) mixture, pH 2, as mobile phase. The flow rate was set at 1 ml/min and the emission and excitation were 350 and 238 respectively. The lower limit of detection was 0.05 ng/ml and lower limit of quantization was 0.2ng/ml. The intra and inter-day precisions (CV %) of the quality control samples were 2.45- 7.27 and 0.52-7.92% respectively. The recovery of method was %99.48±8.5. The method was applied to a bioequivalence study in human.

KEYWORDS: Carvedilol; Human plasma; HPLC; Bioequivalence

Download this article as: 
Copy the following to cite this article:

Adib N, Shekarchi M. A new HPLC Method for Determination of Carvedilol in Human Plasma and its Application in Bioequivalence Studies. Biosci Biotech Res Asia 2015;12(1)
Copy the following to cite this URL:

Adib N, Shekarchi M. A new HPLC Method for Determination of Carvedilol in Human Plasma and its Application in Bioequivalence Studies. Biosci Biotech Res Asia 2015;12(1).Available from: https://www.biotech-asia.org/?p=5707>

[ HTML Full Text]

Back to TOC